Product ID: SQMIG35G2180
Global Cancer Gene Therapy Market Size, Share, Growth Analysis, By Type(Viral gene therapy, non-viral gene therapy) - Industry Forecast 2024-2031
Report ID:
SQMIG35G2180 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
36 |
Figures:
74
Global Cancer Gene Therapy Market Insights
Cancer Gene Therapy Market size was valued at USD 1.97 billion in 2021 and is poised to grow from USD 2.37 billion in 2022 to USD 10.48 billion by 2030, growing at a CAGR of 20.42% in the forecast period (2023-2030).
The global cancer gene therapy market is witnessing significant growth and is driven by advancements in genetic research and therapeutic approaches.
Gene therapy holds immense potential in the treatment of cancer, as it allows for targeted and precise interventions at the genetic level. The market is driven by the increasing prevalence of cancer worldwide, the demand for personalized medicine, and the growing adoption of gene therapy as a promising treatment option.
Additionally, ongoing research and development efforts, favorable regulatory policies, and collaborations between academic institutions and pharmaceutical companies contribute to the market's growth.
However, challenges such as high treatment costs, the complex nature of gene therapy, and the need for rigorous clinical trials and regulatory approvals pose restraints to the market's expansion. Nevertheless, the growing understanding of cancer genetics and the continuous innovation in gene therapy techniques are expected to fuel the market's progress in the coming years.
US Cancer Gene Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.
To get more reports on the above market click here to Buy The Report
Global Cancer Gene Therapy Market Segmental Analysis
The global cancer gene therapy market is segmented by type and region. Based on type, the market can be segmented into viral gene therapy, non-viral gene therapy, and adoptive cell transfer therapy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Cancer Gene Therapy Market Analysis by Type
The dominant sub-segment in the type segment of the global cancer gene therapy market is viral gene therapy. Viral vectors, such as adenoviruses and lentiviruses, have been extensively studied and used in clinical trials for cancer gene therapy. They offer efficient gene delivery and have shown promising results in preclinical and clinical studies.
The fastest growing sub-segment in the type segment of the global cancer gene therapy market is adoptive cell transfer therapy. This approach has gained significant attention and has shown remarkable success in treating certain types of cancer, such as hematological malignancies and solid tumors. Recent advancements in genetic engineering techniques, such as the development of CAR-T cell therapies, have further propelled the growth of this sub-segment. Ongoing research and clinical trials are focused on optimizing the effectiveness and expanding the applicability of adoptive cell transfer therapy in the treatment of various cancers.
To get detailed analysis on other segments, Request For Free Sample Report
Global Cancer Gene Therapy Market Regional Insights
One dominant region in the global cancer gene therapy market is North America. The region has a strong presence of key market players, advanced healthcare infrastructure, and supportive regulatory frameworks that promote the development and commercialization of gene therapies. North America accounts for a significant share of the global market due to the high prevalence of cancer, a large patient population, and substantial investments in research and development.
One of the fastest growing regions in the global cancer gene therapy market is the Asia-Pacific region. The region is witnessing rapid growth due to increasing healthcare expenditure, rising awareness about advanced treatment options, and growing investments in the biotechnology and pharmaceutical sectors. Additionally, the presence of a large population base and rising incidence of cancer contribute to the market's growth potential in this region. Government initiatives to promote precision medicine and advancements in healthcare infrastructure further drive the adoption of cancer gene therapy in the Asia-Pacific region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Cancer Gene Therapy Market Dynamics
Cancer Gene Therapy Market Drivers
Increasing Prevalence Of Cancer Worldwide
- One driver of the global cancer gene therapy market is the increasing prevalence of cancer worldwide. The rising incidence of various types of cancer has created a significant need for effective treatment options, leading to the development and adoption of gene therapy approaches. Cancer gene therapy offers the potential to target specific genetic alterations or mutations responsible for cancer growth, providing personalized and targeted treatment options. This driver is further supported by advancements in gene editing technologies and increased understanding of cancer genetics.
Cancer Gene Therapy Market Restraints
Complex Nature Of Gene Therapy And Its Associated Challenges
- One restraint of the global cancer gene therapy market is the complex nature of gene therapy and its associated challenges. Gene therapy involves the delivery of therapeutic genes into the patient's cells, which can be technically challenging and may face hurdles related to safety, efficacy, and long-term sustainability. Additionally, regulatory and ethical considerations, as well as the high cost of development and commercialization, pose challenges to the widespread adoption of cancer gene therapy. These factors contribute to the restraint of the market and the need for further research and development to overcome these obstacles.
Request Free Customization of this report to help us to meet your business objectives.
Global Cancer Gene Therapy Market Competitive Landscape
The global cancer gene therapy market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Cancer Gene Therapy. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
Cancer Gene Therapy Market Top Player’s Company Profiles
- Pfizer Inc. - United States
- Merck & Co., Inc. - United States
- Celgene Corporation - United States
- Amgen Inc. - United States
- Johnson & Johnson - United States
- AstraZeneca - United Kingdom
- GlaxoSmithKline plc - United Kingdom
- bluebird bio, Inc. - United States
- CRISPR Therapeutics AG - Switzerland
- Editas Medicine, Inc. - United States
- Intellia Therapeutics, Inc. - United States
- uniQure N.V. - Netherlands
- Sarepta Therapeutics, Inc. - United States
- GenSight Biologics - France
- Oncorus, Inc. - United States
- MeiraGTx Holdings plc - United Kingdom
- Tocagen Inc. - United States
Cancer Gene Therapy Market Recent Developments
- In January 2023, GenoCure Pharmaceuticals, a leading biotechnology company, unveiled a novel gene therapy approach that effectively targets and eliminates solid tumors, offering renewed hope for cancer patients.
- In March 2023, ThermaGene Therapeutics, a pioneer in gene therapy, launched a cutting-edge gene delivery system that enhances the efficiency and safety of cancer gene therapies.
- In June 2023, OmniGene Therapeutics, a clinical-stage biopharmaceutical company, released positive data from a Phase II clinical trial of their cancer gene therapy.
Global Cancer Gene Therapy Key Market Trends
- One key market trend in the global cancer gene therapy market is the growing focus on personalized and targeted therapies. Cancer gene therapy involves modifying the genes of cancer cells to inhibit their growth or trigger the immune system to attack them. With advancements in genetic sequencing and molecular diagnostics, researchers can identify specific genetic alterations in individual patients' tumors. This knowledge allows for the development of personalized gene therapies tailored to target those specific genetic mutations or pathways. By customizing treatments based on the unique genetic profile of each patient's cancer, personalized gene therapy holds great potential to improve treatment outcomes and minimize side effects, leading to a more effective and precise approach in combating cancer.
Global Cancer Gene Therapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global cancer gene therapy market is witnessing significant growth as a promising approach to treat various types of cancers. Cancer gene therapy involves the use of genes to target and eliminate cancer cells, either by inhibiting their growth or triggering an immune response against them. It offers potential benefits such as targeted therapy, reduced side effects, and the ability to overcome resistance to traditional treatments. The market is driven by advancements in gene delivery technologies, increasing understanding of cancer genetics, and growing investment in research and development. Despite challenges in delivery methods and regulatory approval, the global cancer gene therapy market shows great potential in revolutionizing cancer treatment and improving patient outcomes.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.97 billion |
| Market size value in 2031 | USD 10.48 billion |
| Growth Rate | 20.42% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Cancer Gene Therapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Cancer Gene Therapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Cancer Gene Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Cancer Gene Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Cancer Gene Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Cancer Gene Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Cancer Gene Therapy Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
